- Investing Ideas
- /
- Household Healthcare Sector
Household Healthcare Sector
Results
2307
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,307 companies
BioSyent
Market Cap: CA$131.7m
Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.
RX
CA$11.70
7D
8.8%
1Y
30.0%
Microbot Medical
Market Cap: US$95.0m
A clinical-stage medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space in Israel and the United States.
MBOT
US$2.54
7D
3.3%
1Y
135.2%
Cuprina Holdings (Cayman)
Market Cap: US$94.4m
A biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds.
CUPR
US$4.55
7D
2.7%
1Y
n/a
Quipt Home Medical
Market Cap: CA$130.3m
Through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States.
QIPT
CA$2.69
7D
24.0%
1Y
-38.7%
Entera Bio
Market Cap: US$93.6m
A clinical stage company, focuses on developing oral peptide or protein replacement therapies for unmet medical needs.
ENTX
US$1.91
7D
-3.5%
1Y
-19.7%
Immunic
Market Cap: US$93.3m
A biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany.
IMUX
US$0.92
7D
-5.9%
1Y
-27.6%
Whitehawk Therapeutics
Market Cap: US$93.1m
An oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments.
WHWK
US$1.93
7D
14.6%
1Y
-0.3%
RetinalGenix Technologies
Market Cap: US$93.0m
RetinalGeniX Technologies Inc., an ophthalmic research and development company, focuses on developing technologies to screen, monitor, diagnose, and treat ophthalmic, optical, and sight-threatening disorders.
RTGN
US$5.02
7D
0%
1Y
n/a
Coherus BioSciences
Market Cap: US$92.7m
A biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States.
CHRS
US$0.82
7D
-1.1%
1Y
-60.8%
Cardiol Therapeutics
Market Cap: CA$128.1m
A clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.
CRDL
CA$1.47
7D
-5.2%
1Y
-50.7%
Corbus Pharmaceuticals Holdings
Market Cap: US$92.6m
A biopharmaceutical company, develops products to defeat serious illness.
CRBP
US$7.41
7D
5.3%
1Y
-83.5%
Milestone Pharmaceuticals
Market Cap: US$92.1m
A biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada.
MIST
US$1.38
7D
17.9%
1Y
-21.1%
Kindly MD
Market Cap: US$91.7m
A healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services.
KDLY
US$22.83
7D
198.4%
1Y
n/a
XBiotech
Market Cap: US$90.5m
A biopharmaceutical company, discovers, develops, and commercializes true human monoclonal antibodies for treating various diseases.
XBIT
US$2.87
7D
-0.3%
1Y
-66.6%
Grown Rogue International
Market Cap: CA$125.0m
A craft cannabis company, focuses on premium flower and flower-derived products.
GRIN
CA$0.53
7D
-1.9%
1Y
-53.5%
Prenetics Global
Market Cap: US$90.3m
A consumer health company, focuses on empowering individuals to take control of their health through science-backed solutions in Hong Kong, Taiwan, the United States, and internationally.
PRE
US$7.30
7D
36.4%
1Y
24.4%
23andMe Holding
Market Cap: US$90.2m
Operates as a consumer genetics testing company in the United States, the United Kingdom, Canada, and internationally.
MEHC.Q
US$3.24
7D
394.7%
1Y
-69.0%
Zentalis Pharmaceuticals
Market Cap: US$89.9m
A clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers.
ZNTL
US$1.28
7D
5.8%
1Y
-88.9%
CareCloud
Market Cap: US$89.7m
A healthcare information technology (IT) company, provides technology-enabled business solutions, Software-as-a-Service offerings, and related business services to healthcare providers and hospitals primarily in the United States.
CCLD
US$2.03
7D
0%
1Y
-25.1%
FONAR
Market Cap: US$89.4m
Engages in the designing, manufacturing, and selling magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States.
FONR
US$13.70
7D
11.9%
1Y
-11.4%
Medicus Pharma
Market Cap: US$89.3m
A biotech/life sciences company, focused on accelerating the clinical development programs of novel and disruptive therapeutic assets.
MDCX
US$7.71
7D
22.0%
1Y
n/a
Oramed Pharmaceuticals
Market Cap: US$87.8m
Engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins.
ORMP
US$2.11
7D
-4.5%
1Y
-8.3%
Elicio Therapeutics
Market Cap: US$87.7m
A clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer.
ELTX
US$5.36
7D
-0.9%
1Y
-39.5%
Sera Prognostics
Market Cap: US$87.4m
A women’s health company, discovers, develops, and commercializes blood-based biomarker tests and predictive analytic products and services in the United States.
SERA
US$2.12
7D
-9.8%
1Y
-74.5%
Climb Bio
Market Cap: US$85.8m
A clinical-stage biotechnology company, focuses on developing therapies for immune-mediated diseases.
CLYM
US$1.24
7D
-2.4%
1Y
-84.2%
Paradigm Biopharmaceuticals
Market Cap: AU$132.4m
Engages in the research and development of therapeutic products for human use in Australia.
PAR
AU$0.34
7D
-4.2%
1Y
38.8%
Champions Oncology
Market Cap: US$85.0m
A technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States.
CSBR
US$5.98
7D
-7.6%
1Y
27.8%
Pliant Therapeutics
Market Cap: US$84.1m
A biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases.
PLRX
US$1.33
7D
-2.2%
1Y
-90.6%
OncoCyte
Market Cap: US$84.1m
Operates as a precision diagnostics company in the United States and internationally.
OCX
US$3.07
7D
18.1%
1Y
5.6%
Anixa Biosciences
Market Cap: US$84.0m
A biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology.
ANIX
US$2.56
7D
0.4%
1Y
-1.5%
Odysight.ai
Market Cap: US$84.0m
Develops, produces, and markets visualization AI solutions in Israel, the United States, and internationally.
ODYS
US$5.28
7D
-5.8%
1Y
-20.3%
SomnoMed
Market Cap: AU$129.7m
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe.
SOM
AU$0.60
7D
17.6%
1Y
130.8%
Senti Biosciences
Market Cap: US$83.5m
A clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases.
SNTI
US$3.22
7D
0.3%
1Y
-11.6%
Genetic Signatures
Market Cap: AU$129.5m
Operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas.
GSS
AU$0.57
7D
-4.2%
1Y
-25.0%
Adagene
Market Cap: US$83.4m
A clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People’s Republic of China.
ADAG
US$1.56
7D
-9.3%
1Y
-39.8%
Owlet
Market Cap: US$82.8m
Provides digital parenting solutions in the United States, the United Kingdom, and internationally.
OWLT
US$4.99
7D
-5.5%
1Y
31.3%